Physician

Arvinder Mokha, M.D.

According to 2025 Medicare claims, Arvinder Mokha, M.D. (NPI: 1235106352) practices allergy/immunology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is THE POLYCLINIC PLLC (NPI: 1174594634; TIN: 910369070) and primary practice location at 98104-1132. Mokha is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Mokha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 133,384 HCPCS/CPT codes, and received $1,933,076 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 851 prescription claims across 154 beneficiaries totaling $181,805 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 115 claims. Open Payments data shows 2 records totaling $168. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $115,845 to $1,933,076. Similarly, Part D prescription costs have moved sharply higher in recent years, from $53,605 to $181,805. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $147 to $2,849.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	138	5,164	$115,845
2016	173	6,896	$145,403
2017	198	6,913	$136,052
2018	209	10,196	$217,463
2019	208	10,888	$231,530
2020	173	7,981	$173,460
2021	209	11,158	$255,365
2022	248	22,972	$431,151
2023	431	98,981	$1,333,455
2024	424	133,384	$1,933,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	372	$53,605
2016	95	339	$55,116
2017	111	390	$55,861
2018	121	516	$97,504
2019	115	531	$114,921
2020	120	580	$115,943
2021	130	633	$176,918
2022	126	718	$230,481
2023	136	781	$312,084
2024	154	851	$181,805

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	13	$52,704
2019	N/R	60	$52,952
2020	N/R	105	$159,932
2021	N/R	90	$158,940
2022	N/R	123	$157,885
2023	N/R	128	$178,727
2024	N/R	115	$104,653

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	66	189	$121
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	62	62	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	60	69	$74
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	154	431	$58
95004	Test for allergy using allergenic extract	57	2,115	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	20	560	$74,482
Arnuity Ellipta	Fluticasone Furoate	60	3,120	$24,483
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	900	$19,200
Advair Hfa	Fluticasone Propion/Salmeterol	25	960	$11,664
Breo Ellipta	Fluticasone/Vilanterol	22	780	$9,805

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	15	$35,595
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$29,962
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$28,650
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	27	$8,901
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	23	$1,288

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$168	Genentech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arvinder Mokha, M.D.?

Tedicare shows public-source Medicare data for Arvinder Mokha, M.D. (NPI 1235106352), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arvinder Mokha, M.D. have ACO affiliation data?

Arvinder Mokha, M.D. is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Arvinder Mokha, M.D.?

Arvinder Mokha, M.D. is linked to THE POLYCLINIC PLLC (billing NPI 1174594634) in the available physician profile data.

Does Arvinder Mokha, M.D. have Open Payments data?

Arvinder Mokha, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.